Immunome, Inc.IMNMNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+218.0%
5Y CAGR+75.0%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+218.0%/yr
vs +88.7%/yr prior
5Y CAGR
+75.0%/yr
Recent acceleration
Acceleration
+129.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
16.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$653.48M+355.9%
2024$143.35M+45.3%
2023$98.68M+385.6%
2022$20.32M-58.7%
2021$49.23M+23.8%
2020$39.77M+1463.7%
2019$2.54M+58.7%
2018$1.60M-